cagrisema cagrilintide semaglutide phase 3 2025 Cagrilintide–semaglutide (CagriSema) versus or in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, study How much weight can you

It appears to stimulate the expression of growth factors and support the structural repair of axons and myelin sheaths, highlighting its potential as a therapeutic agent for various forms of neuropathy and nerve damage

2.3 Excretion, metabolism, and tissue distribution of BPC157 In the aforementioned studies, we characterized the pharmacokinetic profile of prototype BPC157 using high-performance liquid chromatography (HPLC) in rats and dogs

I think the interest is very understandable

Slowing the ladder is always the safer lever

Mostly because its having a moment. BPC-157 has been a frequent guest on the Joe Rogan podcast, receives backing from Gary Brecka (a purveyor of nasal-sprayed BPC-157 for $375 a pop), and got a boost on Andrew Hubermans popular neuroscience-ish podcast

Measure carefully with a 3 mL syringe, not an insulin syringe which maxes out at 1 mL and would require multiple draws